A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels

Maximum available EOS measurement irrespective of exacerbations may be relevant when considering therapy. These data showed low IgE/Low EOS to be more benign and high EOS groups at increased risk of frequent, severe exacerbations.